Skip to main content
Clinical Trials/NCT01331564
NCT01331564
Completed
Phase 3

Electronically-Mediated Weight Interventions for Pregnant and Postpartum Women

University of Rochester1 site in 1 country1,641 target enrollmentMay 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Gestational Weight Gain
Sponsor
University of Rochester
Enrollment
1641
Locations
1
Primary Endpoint
Proportion of women whose gestational gain is within the recommended gestational weight gain Institute of Medicine Guidelines in kilograms
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.

Detailed Description

This study seeks to expand the understanding of how to slow the accumulation of weight in childbearing women. The intervention goals are to decrease the prevalence of excessive pregnancy weight gain and mean weight retention in the first 18 months postpartum in socio-economically and racially/ethnically diverse sample of 1,641 pregnant women. Women will be randomly assigned to one of three groups: Intervention Group 1 will receive the intervention program only during pregnancy (e-intervention 1). Intervention Group 2 will receive e-intervention 1 plus intervention for 18 months postpartum (e-intervention 2). Control women will receive non-weight related content during both time periods at the project website. The primary hypotheses for the randomized controlled trial are: H1: The proportion of women in Intervention Groups 1 and 2 who gain more weight in pregnancy than is recommended by the IOM will be 33% less than the proportion of the women in the Control Group who gain excessively and H2: The Control Group will have a higher mean weight retention at 12 months postpartum than Intervention Groups 1 and 2.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
December 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Diana Fernandez

Associate Professor of Public Health Sciences

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • Age 18 - 35 at the time of delivery
  • Consented at or before 20 weeks gestation
  • Intending to be available for a 24 months intervention
  • Plan to deliver in one of the 4 hospitals in Rochester, NY (the study area)
  • Plan to carry the pregnancy to term
  • Plan to keep the baby
  • Read and understand English

Exclusion Criteria

  • BMI \< 18.5 kg/m2 and \> 35.0 kg/m
  • Multiple gestation. If multiple gestation is diagnosed after enrollment participant will be terminated from the study (reasons for termination will be included in the consent form)
  • Medical conditions prior to pregnancy which could influence weight loss or gain: cystic fibrosis, hyperthyroidism, renal insufficiency1, proteinuria1, cerebral palsy, lupus erythematosus; rheumatoid arthritis, Crohns disease (severity and other autoimmune diseases evaluated case by case), ulcerative colitis, maternal congenital heart disease (patients are often underweight); hypertension treated with medication2,
  • Psychiatric medication associated with major weight gain or loss (e.g.; Lithium \& Divalproex) Common Criteria
  • Household member on study staff
  • Past or planned (within the next 24 months) weight loss surgery (e.g. gastric bypass, lap band, or liposuction); current participation in a commercial weight loss program (e.g. Weight Watcher's, Jenny Craig); currently enrolled or planned to enroll in a weight loss or another weight gain prevention study
  • Participants will be excluded during screening if they report regular use of systemic steroids, prescription weight loss drugs, and/or diabetes medications (oral or injected- insulin, metformin, byetta, TZDs, other). "Regular use" is defined as "taking this medication most days of the week for the previous month"
  • Current treatment for eating disorder
  • Positive screening for bulimia
  • Weight loss of more than 15 pounds in the three months prior to pregnancy

Outcomes

Primary Outcomes

Proportion of women whose gestational gain is within the recommended gestational weight gain Institute of Medicine Guidelines in kilograms

Time Frame: 40 weeks

Gestational weight gain is the result of the last predelivery weight minus the prepregnancy weight (or early pregnancy weight).

Postpartum weight retention in kg at 12 months postpartum

Time Frame: 1.5 years

The difference between the weight at 12 months postpartum and the pre-pregnancy weight (or early pregnancy weight. Participants will be followed for a maximum of 2 years from recruitment in early pregnancy to 18 months postpartum. The final outcome in the postpartum period is postpartum weight retention at 18 months. Interim measure of postpartum weight will be collected at 6 and 12 months for analyses. The primary hypothesis for the postpartum period is weight retention at 12 months postpartum.

Secondary Outcomes

  • Caloric Intake in Kilocalories(2 years)
  • Physical activity as an average weekly energy expenditure (METS)(2 years)
  • Postpartum weight retention at 18 months(2 years)

Study Sites (1)

Loading locations...

Similar Trials